GBS Inc. Announces Application for FDA Breakthrough Device :

NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...

Related Keywords

United States , American , Spiro Sakiris , Asia Pacific , Tim Mccarthy , Steven Boyages , Biosensx North America Inc , Linkedin , Lifesci Advisors , Twitter , Company Contact , Drug Administration , Purpose Of The Program , Nasdaq , Life Science Biosensor Diagnostics Pty Ltd , Gbs Inc , Exchange Commission , Breakthrough Devices Program , Newcastle University , Devices Breakthrough Program , Securities Exchange , Rapid Saliva Glucose Test , Breakthrough Device , Breakthrough Program , Saliva Glucose , Biosensor Platform , North America , North American , Rapid Saliva Glucose Tests , Devices Program , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Sci Advisors , Chief Financial , Nasdaq Gbs , Jobs , Nc ,